About (3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one
(3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one (PubChem CID 160549217) has the molecular formula C16H19BrN2O2
and a molecular weight of 351.24 g/mol. Its IUPAC name is (3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one.
Analyze (3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one?
The IUPAC name of (3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one (CID 160549217) is (3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one.
What is the SMILES notation for (3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one?
The canonical SMILES for (3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one is Cc1c2c(O[C@H](C)[C@H]3CCC(=O)C3)cc(Br)cc2nn1C.
What is the InChIKey of (3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one?
The InChIKey is ANNSQUSKGGXUPF-MNOVXSKESA-N. The full InChI is InChI=1S/C16H19BrN2O2/c1-9-16-14(18-19(9)3)7-12(17)8-15(16)21-10(2)11-4-5-13(20)6-11/h7-8,10-11H,4-6H2,1-3H3/t10-,11+/m1/s1.
What are the key properties of (3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one?
(3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one has a molecular weight of 351.24 g/mol, XLogP of 3.78, 3 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-3-[(1R)-1-(6-bromo-2,3-dimethylindazol-4-yl)oxyethyl]cyclopentan-1-one is sourced from PubChem (CID 160549217), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).